MK2 Inhibitors as a Potential Crohn’s Disease Treatment Approach for Regulating MMP Expression, Cleavage of Checkpoint Molecules and T Cell Activity
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.